PUOTI MASSIMO

Piralla, A., Mileto, D., Rizzo, A., Ferrari, G., Giardina, F., Gaiarsa, S., et al. (2024). Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy. TRAVEL MEDICINE AND INFECTIOUS DISEASE [10.1016/j.tmaid.2024.102698]. Dettaglio

Moschese, D., Raccagni, A., Giacomelli, A., Piralla, A., Rossotti, R., Raimondi, A., et al. (2024). Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024. CLINICAL INFECTIOUS DISEASES [10.1093/cid/ciae184]. Dettaglio

d’Arminio Monforte, A., Tavelli, A., Di Biagio, A., Sarmati, L., Marchetti, G., Bai, F., et al. (2024). Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkae081]. Dettaglio

Piemonti, L., Landoni, G., Voza, A., Puoti, M., Gentile, I., Coppola, N., et al. (2023). Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study. INFECTIOUS DISEASES AND THERAPY, 12(10), 2437-2456 [10.1007/s40121-023-00871-5]. Dettaglio

Zamprogna, G., Frustaci, A., Travi, G., Borella, C., Reda, G., Motta, M., et al. (2023). Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi. HEMASPHERE, 7(5), 1-4 [10.1097/HS9.0000000000000880]. Dettaglio